Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fully Automated Gram Stain Launched

By LabMedica International staff writers
Posted on 30 Oct 2013
A fully automated Gram Stain Kit has been launched globally on the BenchMark Special Stains platform.

The Gram Staining Kit aids pathologists in the most basic classification of bacteria into Gram-positive and Gram-negative bacteria in fixed tissue samples. More...
Gram stain classification is clinically useful as it provides an initial indication of the nature of a patient's infection.

The Gram stain is part of a family of histochemical special stains that many laboratories around the world still run manually today. In automating the stain, Ventana (VMSI; Tucson, AZ, USA) offers an efficient and automated method to perform this technically challenging assay, enabling them to achieve increased productivity, consistency, and testing quality.

"Tissue diagnostics play a critical role in enabling accurate diagnosis and treatment decisions for cancer patients. Ventana provides laboratories, pathologists, and their patients with novel assays, and the company is empowering its customers to achieve greater efficiencies by automating common, yet labor-intensive tests like the Gram stain," says Mara G. Aspinall, president, Ventana Medical Systems, Inc.

The Gram Staining kit is the newest addition to the Ventana product offerings on the fully automated BenchMark Special Stains platform launched in mid-2012. The kit offers two counterstain options and testing protocol flexibility to meet pathologists' individual preferences.

"The new Gram Staining Kit will provide our customers visual consistency and clarity rarely achieved with manual Gram staining protocols. Our commitment to quality and advancing diagnostic consistency through world-class automation shines with this new product," said Adrian Ralph, vice president, Primary Staining, Ventana Medical Systems, Inc.

The VENTANA Gram Stain Kit is being launched as a US Class I exempt/ CE-IVD product.

Related Links:

Ventana



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.